Home
overview

The point of care diagnostic testing market is forecast to expand from US$13.4 billion in 2008 to over US$22.5 billion in 2013 and comprise 25% of the total in vitro diagnostics market. Growth has been driven in part due to the promise of speed, convenience, and improved patient outcomes that point of care testing can bring.

Drawing on key opinion leaders in the field of POC Diagnostics, SMi's 7th annual Point of Care Diagnostics: Market Adoption and Technology Trends will present you with an insight into the many challenges facing this industry and provide an unsurpassed opportunity to obtain information you need in order to remain competitive in this evolving market.

Join registered delegates including:

Abbott Diagnostics, the HPA, Alere, Biovate, bioMérieux, Bridgehead International, Chempaq, Charisma L.L.C, Diasys, Laboratorios CINFA, Merck Sharp and Dohme, Ortho Clinical Diagnostics, Invetech, NHS, Phadia, Hemocue, Philips, Radiometer, Reckitt Benckiser, Roche Diagnostics, Systagenix, Stratophase, Soligie, Werfen, Vivacta and many more.

 


The conference will examine critical issues including:

Markets & Commercial Strategies: Understanding the drivers and barriers to PoC diagnostics adoption and competing in the evolving worldwide point of care diagnostics market

Reimbursement, Remuneration and Regulation: Updated guidance and cost effectiveness analyses

Technology & Connectivity: New technologies, personalised medicine and managing point of care diagnostics in a networked world

Point of care diagnostics image


Keen to see the detailed programme? Click here

Want to download the brochure?  Click here

Want to register your place? Click here

How you will benefit:

Understand, discuss and debate the drivers and barriers to POC diagnostic adoption
Strategies to compete in the evolving worldwide POCT market
Study reimbursement, remuneration and regulation
Discover new technologies and connectivity innovations

Key presentations include:

  • Predicting and planning for the POC market of the future, from Roche Diagnostics 
  • The promise of POC diagnostics in the developing world, from Daktari Diagnostics 
  • Meeting the demands of healthcare systems and patients, from Adams Business Associates 
  • Future POC platforms, from the Technology Strategy Board 
  • New technologies for near & on-patient diagnosis and monitoring, from The University of Cambridge 
  • Picomolar sensitivty with a POC technology, from Ortho Clinical Diagnostics

 

See the full programme 

Point of care diagnostics image

 

The conference is directed at:

  • Chief Scientific Officers
  • Chief Technical Officers
  • Directors/Heads/VPs of Diagnostic Research and Development 
  • Directors/Heads/VPs of Business Development 
  • Directors/Heads/VPs of Point of Care 
  • Hospital CEOs, CIOs, CFOs 
  • Hospital Chief Pathologists / Head of Lab Services
  • Physicians 
  • Pharmacists 
  • Pathologists
  • Clinical Scientists
  • Policy Makers
  • Product/Service Development Manager

This annual event has been attended in previous years by organisations including:

  • Abbott Diagnostics
  • Boots Centre of Innovation
  • FDA
  • Hemocue AB
  • Inverness Medical
  • MHRA
  • Mitsubishi Chemical Europe Gmbh
  • NHS Institute for Innovation and Improvement
  • Nova Biomedical
  • Ortho Clinical Diagnostic Systems
  • Radiometer Medical
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics
  • Novozymes

 

Conference programme

8:30 Registration & Coffee

9:00 Chairman's opening remarks

William Rodriguez

William Rodriguez, Chief Executive Officer, Daktari Diagnostics

9:10 The future of point of care diagnostics

Thomas Raichle

Thomas Raichle, Senior Director, Roche Diagnostics

  • The professional POC market: past, present and future
  • Decentralising diagnostics
  • Barriers to adoption
  • Growth opportunities and promising world markets
  • Looking towards a POC market of the future
  • 9:50 Competing in the evolving worldwide POCT market

    Harry Glorikian

    Harry Glorikian, Managing Partner, Scientia Advisors

  • Entrance considerations
  • Market dynamics
  • Effect of USA health reform act
  • Innovative business models and strategies to drive your long term POCT programme
  • 10:30 Morning Coffee

    11:00 Point of care diagnostics in the developing world

    William Rodriguez

    William Rodriguez, Chief Executive Officer, Daktari Diagnostics

  • The promise of emerging markets
  • Unique needs and considerations
  • Challenges to be addressed in successful commercialisation
  • Breaking into the distribution channel
  • Financing R&D for global health diagnostics
  • Case study: enabling POCT in remote African towns and villages
  • 11:40 Interactive panel discussion

  • Key drivers
  • Unmet needs
  • Trends within the established POC testing disciplines
  • Improving penetration
  • Rapid testing is here, but is healthcare ready?
  • Regional differences and the challenges this brings
  • William Rodriguez

    William Rodriguez, Chief Executive Officer, Daktari Diagnostics

    David Huckle

    David Huckle, Chief Executive, Adams Business Associates

    Thomas Raichle

    Thomas Raichle, Senior Director, Roche Diagnostics

    Tim Pitfield

    Tim Pitfield, Market Deveopment Manager, Veridex LLC, a Johnson & Johnson Company

    12:20 Networking Lunch

    13:50 Meeting the demands of healthcare systems and patients

    David Huckle

    David Huckle, Chief Executive, Adams Business Associates

  • What are the unmet needs in the POC diagnostics industry?
  • Aligning clinical benefits, economic benefits and savings
  • Developing the right clinical cost/benefit data to justify adoption
  • Analytical quality
  • Education of users
  • 14:30 POCT in the home

    Bill Cunningham

    Bill Cunningham, Managing Director, CDx

  • Markets and forecasts
  • Promising segments, technologies and opportunities
  • Challenges away from the clinical setting
  • Home connectivity
  • 15:10 Afternoon Tea

    15:40 Reimbursement and Adoption

    Tim Pitfield

    Tim Pitfield, Market Deveopment Manager, Veridex LLC, a Johnson & Johnson Company

  • Summary of the different bodies involved
  • The adoption landscape
  • Hurdles preventing adoption
  • Case study example
  • Implications for the PoC diagnostics industry
  • 16:20 The role of POCT in personalised medicine

    Eddie Blair

    Eddie Blair, Director, Integrated Medicines Ltd

  • The state of personalised healthcare
  • From diagnostics to personalized medicine
  • Factors inhibiting adoption and challenges to be faced
  • Data required to tailor care to individual patients
  • 17:00 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Christopher Lowe

    Christopher Lowe, Director of the Institute of Biotechnology, Professor of Biotechnology, Cambridge University

    9:10 New technologies for near and on-patient diagnosis and monitoring

    Christopher Lowe

    Christopher Lowe, Director of the Institute of Biotechnology, Professor of Biotechnology, Cambridge University

  • Key considerations for new sensor technologies  
  • Optical and acoustic approaches 
  • Discrete and real-time monitoring 
  • On-patient, wearable and mobile systems
  • 9:50 Managing point-of-care testing in a networked world

    Fabrizio Mastrantonio

    Fabrizio Mastrantonio, International Marketing Manager, A Menarini Diagnostic S R L

  • Where is point of care testing really going?
  • The growing role of connectivity
  • The role of POCT glucose testing in the hospital settings
  • POCT in autoimmunity
  • Opportunities to extend POCT in the high street pharmacy
  • 10:30 Morning Coffee

    11:00 Future POC platforms

    Penny Wilson

    Penny Wilson, Lead Specialist, Detection and Identification Of Infectious Agents, Technology Strategy Board

  • Emerging Technologies for POCT
  • Clinical utility
  • Challenges of adoption
  • Future opportunities
  • 11:40 Picomolar sensitivity with a point of care technology

    Marsha Oenick

    Marsha Oenick, Director, Product Development, Ortho-Clinical Diagnostics

  • Microstructured plastic chip
  • Managing flow of sample and reagents
  • Data on two model systems demonstrating picomolar sensitivity
  • 12:20 Networking Lunch

    13:20 Non invasive NIR diagnostic technology & biometric products

    Richard Gill

    Richard Gill, Consultant, Genomic Healthcare Strategies

  • Clinical correlations & relevance
  • Diagnostic or device - 513(g), pre IDE & 510(k)
  • Reimbursement
  • Proof of principle in the field
  • Commercialisation through OEM partners
  • 14:00 Case study: POCT for the NHS Health Check

    Devaki Nair

    Devaki Nair, Consultant Clinical Pathologist, Royal Free Hospital

  • Past vs. present testing
  • Understanding POCT requirements from clinical standpoint
  • Vascular checks outreach programme outcome
  • Needs that remain to be met, e.g. serum creatinine testing
  • 14:40 Integration of M-Health, POCT and Microfluidics

    Richard Holmes

    Richard Holmes, Research Fellow in Microfluidics, University of Ulster

  • Developing a 'one-stop-shop'
  • Technology overview
  • Importance of addressing clinician needs
  • True advantages and changes to the way medicine is practiced
  • 15:20 Afternoon Tea

    15:50 Novel PoC systems for blood cell counting

    Björn Ekberg

    Björn Ekberg, Chief Scientific Officer, Chempaq A/S

  • Systems for WBC and CBC analytes
  • Function of disposable cassettes
  • Performance
  • 16:30 Enhancing POCT with new technologies

    Rita Stella

    Rita Stella, Medical Technology Consultant, The Technology Partnership Plc (Ttp)

  • New functionalities for existing assays
  • Adding value by design
  • More information and less complexity
  • 17:10 Quantitative PoC diagnostics

    Oliver Hofmann

    Oliver Hofmann, Head of Microfluidics, Molecular Vision Ltd.

  • Key considerations for optical detection in disposable PoC diagnostic technology
  • Integration of lab-on-a-chip with organic LEDS and photodetectors
  • Application to multiplexed assays
  • Integration of other optical components
  • 17:50 Chairman’s Closing Remarks and Close of Day Two

    +

    Crowne Plaza - The City

    19 New Bridge Road
    London EC4V 6DB
    United Kingdom

    Crowne Plaza - The City

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.